Surgery Partners Q3 revenue up 12.7% to $559.2M; raises FY EBITDA guidance to $325-330M

Surgery Partners, Inc.

2021-Q3 EPS reported -$1.19 revenue$1,614,900,000

Revenue $559.2M (+12.7% YoY); net loss $22.9M; adjusted EBITDA $76.4M (+25% YoY).
Same-facility revenue +8.3%, case volume +6.2% vs prior year quarter.
FY 2021 adjusted EBITDA guidance raised to $325M-$330M.
Deployed over $130M on acquisitions YTD; 3 ASCs bought in Aug; $225M under LOI.
Cash $330.4M; revolver capacity $163M; net debt/EBITDA ratio 6.25x.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.